Pubblicazioni

Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor Î±-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial

2025 - THE LANCET ONCOLOGY

Van Gorp, Toon; Moore, Kathleen N; Konecny, Gottfried E; Leary, Alexandra; GarcÃa-GarcÃa, Yolanda; Banerjee, Susana; Lorusso, Domenica; Lee, Jung-Yun; Moroney, John W; Caruso, Giuseppe; Klasa-Mazurkiewicz, Dagmara; Tromp, Jacqueline; Martin, Lainie P; Breuer, Shani; Leath, Charles A; Cibula, David; Weroha, S John; EstÃ©vez-GarcÃa, PurificaciÃ³n; O'Malley, David M; Miller, Rowan E; Coffman, Lan; Scandurra, Giuseppa; Berton, Dominique; Li, Lingling; Zagadailov, Erin; Diver, Elisabeth J; TrÃ©dan, Olivier; Hilpert, Felix